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Copenhagen, Denmark 
Objective: To present data on episodes of fungemia in a Danish tertiary-care university hospital admitting all types of 
patients and to compare the data with previous findings from the same hospital. 
Methods: Retrospective identification of episodes of fungemia from 1989 to '1994 and collection of data from 
computerized files at the Clinical Microbiology Department at Rigshospitalet and the Mycology Reference Laboratory at 
Statens Seruminstitut. 
Results: The incidence of fungemia increased gradually from 19 episodes in 1989 to 57 episodes in 1994. An earlier 
report from the same hospital showed 20 to 25 episodes of fungemia per year between 1984 and 1988. Candida albicans 
was the dominating species during both periods, accounting for 73% of isolates during 1984 to 1988 and 67% during 
1989 to 1994. However, in the hematology department where fluconazole has been used extensively, C. albicans 
constituted 47% of isolates with Candida krusei and Candida glabrata comprising 25%. 
Conclusions: The incidence of fungemia in our tertiary-care hospital has increased threefold from 1989 to 1994. Candida 
albicans was the dominating cause of fungemia but, in the hematology department, this yeast accounted for less than 
half of the isolates during the same time period. 
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The increasing incidence of fungemia seen in recent 
years is associated with the widespread use of broad- 
spectrum antibiotics, immunosuppressives, permanent 
indwelllng catheters, and major cardiac and abdominal 
surgery, among others. The majority of studies have 
involved speciahzed institutions and particular groups 
of patients, such as organ transplant and cancer patients 
[l-31. This report presents the data on episodes of 
fungemia in a tertiary-care hospital admitting all types 
of patients and compares these data with previous 
findings from the same hospital. 
MATERIALS AND METHODS 
Rigshospitalet is a 1400-bed tertiary-care university 
hospital, serving mainly patients fiom eastern Denmark, 
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which has a population of approximately two million 
people. The hospital covers all medical and surgical 
specialities, including units for heart, lung, liver and 
bone marrow transplantation. The annual number of 
blood cultures performed at the hospital's clinical 
microbiology laboratory was approximately 10,000 
during the period from 1989 to 1994. 
Episodes of fungemia were retrospectively identi- 
fied in our computerized files between January 1, 1989 
and December 31, 1994. An episode was defined as at 
least one positive blood culture with h n p  during a 
single hospitalization. Blood cultures were performed 
with a three-bottle broth system (Statens Serurninstitut), 
which consists of a set of three bottles containing an 
aerobic medium, a mycological medium and an 
anaerobic medium. Cultures were incubated for 7 days 
at 35°C with daily inspections. Blind subcultures were 
performed on chocolate agar after 5 days. All hngal 
isolates were referred to the Mycology Reference 
Laboratory at Statens Seruminstitut for identification 
according to standard methods [4]. Eight isolates were 
not referred either because of a laboratory mistake or 
death of the patient. 
124 
Bruun: Fungemia i n  a Danish university hospital  125  
RESULTS 
A total of 226 episodes of fungemia were identified in 
217 patients from 1989 to 1994. However, four 
episodes provided two fungal isolates, resulting in a 
total of 230 strains. Seven patients had two episodes of 
fungemia during 'the 6-year study period, and one 
patient had three episodes. The 217 patients comprised 
92 women and 125 men, ranging from 6 days to 83 
years old. Of the 226 episodes, approximately 40% were 
derived from the various departments of internal 
medicine, including the infectious diseases service. 
Hematology-oncology adult patients accounted for 
approximately 20% of cases whereas almost all of the 22 
cases (10%) from the pediatric department occurred in 
children with malignancy. The neonatal intensive care 
unit accounted for 5% of cases, and 10% originated 
from the intensive care unit per se. Various surgical 
specialities accounted for the remaining 15% of cases, 
with abdominal and cardiac surgery dominating. 
Figure 1 shows the annual incidence of hngemia 
from 1989 to 1994 and the distribution of Candida 
albicans/non-C. albicans during that time. The annual 
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Figure I Annual incidence of fungemia during 1989 to 
1994 and the distribution between Candida albiuns and 
non-C. albicans. m= C. albicans; 5= non-C. albicans; 
= polymicrobial fungemia; = unreferred isolates. 
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incidence of fungemia increased gradually from 19 
episodes in 1989 to 57 episodes in 1994. The percen- 
tage of C. albicans isolates varied during the period, 
with a maximum of 81% in 1989 and a minimum of 
59% in 1991. There was no statistically significant 
dfference in the ratio of C. albicans episodes to other 
Candida species between 1989 and 1994. 
The various fungal species and the tiequency of 
their occurrence fiom 1989 to 1994 are listed in Table 
1 (excluding the eight unreferred yeasts). The species 
distribution for fungemias between 1984 and 1988 
from an earlier study at our hospital is included for 
comparison [5]. By far, the most prominent species 
during both periods w a s  C. albicans, which accounted 
for 73% and 67% of isolates, respectively. Cryptococcus 
neOfrrnans increased from the period 1984 to 1988 
compared with 1989 to 1994, but this did not reach 
statistical significance. All cases of C. neoforrnans 
fbngemia occurred in human immunodeficiency virus 
(HIV)-positive patients. The two species with an 
inherently low sensitivity to fluconazole, Candida krusei 
and Candidaglabrata, did not show a significantly differ- 
ent frequency between the two periods when consider- 
ing fungemias from the whole hospital. The picture was 
considerably changed, however, when the hematology 
department was considered separately: 41 isolates were 
derived from patients in ths  department during 1989 
to 1994 and, of these, three isolates were not identified 
further. Of the remaining 38 isolates, only 18 (47%) 
were C. albicans. Of the 20 non-C. albicans isolates, six 
were C.  krusei and four were C., glabrata. Thus, these 
two species accounted for 26% of all fungal blood 
isolates from adult hematology patients. 
Table 1 Species isolated from episodes of fungemia fiom 
1984 to 1988 and fiom 1989 to 1994 at Rigshospitalet in 
Copenhagen 
1984 to 1988 1989 to 1994 
Snccies n %  n %  
Candida albicons 
Candida glabrata 
Candida tropiulis 
Candida krusei 
Candida parapsilosis 
Cryptococnrs neoformans 
Candida lusitaniae 
Rhodotorula species 
Candida kehr 
Candida guilliermondii 
Candida norvegensis 
Sarrharomyces cerwisiae 
Other 
Total 
88 73 
5 4 
5 4 
2 2 
5 4 
1 1 
1 1 
0 
0 
2 2 
2 2 
3 3 
6 5 
- 
- 
120 
149 67 
16 7 
16 7 
9 4 
9 4 
9 4 
4 2 
4 2 
3 1 
0 
0 
1 <I 
2 1 
- 
- 
222 
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DISCUSSION 
The findings in this retrospective study show that the 
incidence of fimgemia has been increasing in our 
hospital from 1989 and onwards. An earlier report from 
our hospital demonstrated a stable level of 20 to 25 
episodes per year between 1984 and 1988 151. Our. 
finding of 19 episodes in 1989 fitted this picture well 
but, thereafter, a gradual increase from year to year 
began. This rising incidence of fungemia has been 
observed by others, especdly in institutions that have 
high proportions of immunocompromised patients 
Different factors have probably contributed to this 
increasing incidence of fungemia at our hospital. 
During 1990, heart, lung and liver transplantations 
were added to the repertoire of the hospital, and the 
number of allogenic bone marrow transplantations 
increased substantially. During the same period, intra- 
vascular devices and broad-spectrum antibiotics, 
known risk factors for fungemia [3,5,8,9], were used 
more extensively than before in critically ill patients. 
Furthermore, beginning in 1990, agitation of the 
aerobic bottles of the blood culture system com- 
menced, a factor likely to increase the yield of yeast 
from blood [lo]. 
The distribution of fungal species was in 
accordance with other studies from hospitals admitting 
a l l  types ofpatients [8,11,12] and a previous study from 
our own hospital [5], showing the predominance of C. 
albicans. This is in contrast to reports from cancer 
centers where the percentage of C. albicans among 
fungemia cases is 50% or less [3,9]. In this context, it is 
of interest that only 47% of the isolates from the 
hematology department of our hospital were C. 
albicans. Furthermore, the fact that the two species with 
low sensitivity to fluconazole, C. kncsei and C. glabrata, 
accounted for one-fourth of all fungal blood isolates 
from the hematology department corresponds to the 
widespread use of fluconazole in these patients during 
the last 5 years. The hematology department accounted 
for more than 50% of the total consumption of 
fluconazole in our hospital and 1990 was the first year 
of its extensive use. This change in the dlstribution of 
Candida species due to fluconazole use has also been 
reported by others [13,14]. 
In summary, the incidence of fungemia in our 
tertiary-care university hospital admitting all types of 
patients has been increasing since 1990. The domin- 
ating cause of fungemia is s t i l l  C. albicans although, in 
the hematology department where fluconazole is used 
extensively, C. albicans constitutes less than 50% of 
isolates from 1989 to 1994. 
[6-81. 
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